Scribenote: AI startup Scribenote raises $8.2M in funding round led by Andreessen Horowitz

Write it downa startup that uses AI to generate medical records For veterinarians, said Monday it has raised $8.2 million in an early stage round of financing Led by a venture capital firm Andreessen Horowitz.

Also participating in the fundraising were venture capital firm Inovia Capital and Velocity Fund, which invests in early-stage startups.

It was not immediately clear at what valuation the funds were raised.

Startups deploying artificial intelligence have attracted strong investor interest this year, with five raising more than $1 billion by 2024. Generative AI heavyweight OpenAI is also in talks to raise $6.5 billion in a funding round that would value the company at $150 billion.

Founded in 2019, Scribenote uses artificial intelligence to automate medical record documentation for veterinarians.


It has automated more than 1.5 million medical records in less than a year, the company said.

Discover the stories that interest you


In March this year, Reuters reported that Andreessen Horowitz was close to securing a $7 billion fund that would target startups across multiple industries, including artificial intelligence. It participated in Elon Musk’s company’s $6 billion Series B funding. AI Home xAI in May.

Source link

Disclaimer:
The information contained in this post is for general information purposes only. We make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the post for any purpose.
We respect the intellectual property rights of content creators. If you are the owner of any material featured on our website and have concerns about its use, please contact us. We are committed to addressing any copyright issues promptly and will remove any material within 2 days of receiving a request from the rightful owner.

Leave a Comment